Napo Pharmaceuticals, Inc. Receives Approval From Indian Regulator To Initiate Phase II Clinical Trial For Crofelemer For Acute Infectious, Diarrhea
Fri, 04 Aug 2006 06:00 AM EST
... NapoPharmaceuticals, Inc., (LSE: NAPL. [click link for full article] ...
Related Topics
- Clinical Trials
- Infectious Diseases
- Diarrhea
- Tarceva
- American Indian
- Mononucleosis, Infectious
- Acute Care
- Pharmacology
- Epidemiology
- Trastuzumab
- Psychopharmacology
- Gastroenteritis
- Epidemiology & Prevention of Vaccine-Preventable Diseases
- Emerging Infectious Diseases
- Vaccine Testing & Approval
- Echinacea
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Brainerd Diarrhea

Not Signed In -


